Frost Phillip MD Et Al
Cocrystal Pharma, Inc. · Director, 10% Owner
Frost Phillip MD Et Al is listed in filings as Director, 10% Owner at Cocrystal Pharma, Inc.. This profile follows SEC Form 4 activity through Feb 25, 2026, including purchase activity. Recent filings connect the profile to Cocrystal Pharma, Inc. (COCP), OPKO Health, Inc. (OPK), and Fluent, Inc. (FLNT). The current snapshot covers public activity from Nov 29, 2024 to Feb 25, 2026. Reported amounts are shown as $20.0K to $27.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $115k67.4k shares | BuyFeb 28, 2025 | $1.71 | $1.19 | |
| $70k47.5k shares | BuyJan 28, 2025 | $1.47 | $1.19 | |
| $220k150k shares | BuyJan 17, 2025 | $1.47 | $1.19 | |
| $741k500k shares | BuyJan 15, 2025 | $1.48 | $1.19 | |
| $199k125k shares | BuyDec 13, 2024 | $1.60 | $1.19 | |
| $781k500k shares | BuyDec 11, 2024 | $1.56 | $1.19 | |
| $324647.9k shares | BuyDec 2, 2024 | $0.0005 | $3.73 | |
| $305k199.1k shares | BuyNov 29, 2024 | $1.53 | $1.19 |
Showing 51-58 of 58